Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用:
4-[(Dimethylamino)iminomethyl]benzoic acid is a metabolite of Betrixaban (B329500) which is a novel anticoagulant. An oral direct inhibitor of factor Xa (FXa) for use in the prevention of venous thromboembolism (VTE).